Cargando…
Efficacy and safety of newer P2Y(12) inhibitors for acute coronary syndrome: a network meta-analysis
Whether newer P2Y(12) inhibitors are more efficacious and safer than clopidogrel and whether there is a superior one remain uncertain. We compared the effect of P2Y(12) inhibitors on clinical outcomes in patients with acute coronary syndrome (ACS). Randomized controlled trials comparing clopidogrel,...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545197/ https://www.ncbi.nlm.nih.gov/pubmed/33033323 http://dx.doi.org/10.1038/s41598-020-73871-x |